无排卵
医学
多囊卵巢
不育
二甲双胍
妇科
体外受精
促排卵
怀孕
高促性腺激素缺乏症
妊娠率
促性腺激素减退症
排卵
产科
内分泌学
糖尿病
激素
胰岛素抵抗
生物
遗传学
作者
Bülent Urman,Kayhan Yakın
出处
期刊:PubMed
日期:2006-04-01
卷期号:51 (4): 267-82
被引量:8
摘要
Ovulatory disorders represent a major cause of infertility. The World Health Organization classification offers a useful frame for diagnosis and treatment. Polycystic ovary syndrome (PCOS) is the most common cause of oligoovulation and anovulation. Treatment of infertility associated with PCOS has changed in the last decade due to the introduction of new medications. Insulin-sensitizing drugs, such as metformin, became an integral part of treatment. Aromatase inhibitors will most probably replace clomiphene citrate in the future. Women who fail to ovulate or conceive after first-line treatment options are often referred for gonadotropin treatment. Laparoscopic ovarian drilling, which has been evaluated in well-designed trials, may be an alternative to gonadotropins. In vitro fertilization, which yields high pregnancy rates, is the final treatment option when all else fails. Hypogonadotropic anovulation is treated with exogenous gonadotropins, and little has changed in its management. Women with hypergonadotropic hypogonadism should be counseled for adoption or in vitro fertilization with donated oocytes as spontaneous and treatment-associated pregnancy rates are very low.
科研通智能强力驱动
Strongly Powered by AbleSci AI